Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) Receives Consensus “Hold” Recommendation from Brokerages

0

Fresenius Medical Care AG & Co. KGaA (NYSE: FMS – Get a rating) has been given an average rating of “Hold” by the seventeen research firms that currently cover the company, reports Marketbeat Ratings. Two analysts rated the stock with a sell recommendation, six gave the company a hold recommendation and five gave the company a buy recommendation. The 12-month average target price among analysts who have rated the stock over the past year is $51.71.

FMS has been the subject of a number of recent analyst reports. Zacks Investment Research downgraded shares of Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “hold” rating and set a target price of $35.00 on the stock in a research note Tuesday, January 11. Oddo Bhf has upgraded shares of Fresenius Medical Care AG & Co. KGaA from a “neutral” rating to an “outperforming” rating and has set a price target of €72.00 ($78.26) on the share in a Tuesday, March 1 research report. Credit Suisse Group cut its price target on shares of Fresenius Medical Care AG & Co. KGaA from €66.00 ($71.74) to €61.00 ($66.30) in a research report from the Tuesday, March 1. Societe Generale cut its price target on shares of Fresenius Medical Care AG & Co. KGaA from €61.00 ($66.30) to €57.00 ($61.96) in a Friday 25 research report february. Finally, Berenberg Bank reduced its price target on shares of Fresenius Medical Care AG & Co. KGaA from €84.90 ($92.28) to €83.40 ($90.65) in a research report from the Thursday March 17.

(A d)

Some companies are expected to face major difficulties in this difficult market.

And you may own these stocks… But you should avoid them for now.

Discover the actions to avoid by clicking here.

Shares of Fresenius Medical Care AG & Co. KGaA opened at $33.64 on Friday. Fresenius Medical Care AG & Co. KGaA has a 12 month minimum of $28.75 and a 12 month maximum of $42.45. The company has a market capitalization of $19.71 billion, a price/earnings ratio of 17.16, a PEG ratio of 1.51 and a beta of 1.20. The company has a current ratio of 1.10, a quick ratio of 0.82 and a debt ratio of 0.48. The company’s 50-day moving average price is $32.84 and its 200-day moving average price is $33.00.

Fresenius Medical Care AG & Co. KGaA (NYSE: FMS – Get a rating) last announced its quarterly results on Tuesday, February 22. The company reported earnings per share (EPS) of $0.51 for the quarter, beating analyst consensus estimates of $0.50 by $0.01. Fresenius Medical Care AG & Co. KGaA achieved a net margin of 5.51% and a return on equity of 7.51%. The company posted revenue of $5.31 billion for the quarter, versus a consensus estimate of $5.38 billion. On average, sell-side analysts expect Fresenius Medical Care AG & Co. KGaA to post earnings per share of 2.08 for the current year.

A number of large investors have recently increased or reduced their stakes in the stock. American Century Companies Inc. increased its stake in Fresenius Medical Care AG & Co. KGaA by 3.9% in the third quarter. American Century Companies Inc. now owns 8,239 shares of the company valued at $288,000 after acquiring 307 additional shares in the last quarter. Mercer Global Advisors Inc. ADV increased its stake in Fresenius Medical Care AG & Co. KGaA by 3.3% in the third quarter. Mercer Global Advisors Inc. ADV now owns 12,699 shares of the company valued at $444,000 after acquiring 411 additional shares in the last quarter. Liberty Wealth Management LLC increased its holdings in Fresenius Medical Care AG & Co. KGaA by 71.9% in the third quarter. Liberty Wealth Management LLC now owns 1,234 shares of the company valued at $42,000 after acquiring 516 additional shares last quarter. Dimensional Fund Advisors LP increased its holdings in Fresenius Medical Care AG & Co. KGaA by 1.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 53,824 shares of the company valued at $1,747,000 after acquiring 516 additional shares in the last quarter. Finally, Ellevest Inc. increased its position in Fresenius Medical Care AG & Co. KGaA by 96.6% during the fourth quarter. Ellevest Inc. now owns 1,148 shares of the company valued at $37,000 after purchasing an additional 564 shares during the period. Institutional investors and hedge funds hold 4.89% of the company’s shares.

Fresenius Medical Care AG & Co. KGaA Company Profile (Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Read more

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in Fresenius Medical Care AG & Co. KGaA right now?

Before you consider Fresenius Medical Care AG & Co. KGaA, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes a turn… and Fresenius Medical Care AG & Co. KGaA was not on the list.

While Fresenius Medical Care AG & Co. KGaA currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

Share.

Comments are closed.